Indeed, intervention in AAK1 phosphorylation has been shown useful in clinical trials for the treatment of neurological diseases such as neurological pain, AD, Schizophrenia, and ALS. The gene discussed is AAK1; the disease is amyotrophic lateral sclerosis.